Literature DB >> 8593595

Heparan sulfate and chondroitin sulfate glycosaminoglycan attenuate beta-amyloid(25-35) induced neurodegeneration in cultured hippocampal neurons.

A G Woods1, D H Cribbs, E R Whittemore, C W Cotman.   

Abstract

beta-Amyloid peptide has been reported to be toxic to neurons in vitro and in vivo. The fragment of the beta 1-42 peptide believed to be responsible for this toxicity consists of amino acids 25 to 35. beta-amyloid protein, heparan sulfate (HS) glycosaminoglycan (GAG), and proteoglycan (PG) are all localized throughout the senile plaques found in Alzheimer's disease. Chondroitin sulfate (CS) and dermatan sulfate have also been found at the periphery of senile plaques. We have found that both HS and CS prevented neurite fragmentation and toxicity normally induced by beta 25-35. HS and CS by themselves did not have a significant influence on cell viability, indicating that their protective actions were not due to a general trophic effect. In contrast, cultures treated with HS and beta 1-42 did not show significantly reduced toxicity compared to cultures treated with beta 1-42 alone despite specific binding interactions. These data indicate that one function of GAGs in the brain may be to protect neurons from select toxic insults and injury, and additionally suggest that HS interacts differently with different beta-amyloid fragments. These data further suggest that different beta-amyloid fragments may induce distinct mechanisms of toxicity in vitro.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8593595     DOI: 10.1016/0006-8993(95)00775-l

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

Review 1.  Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?

Authors:  K E Rhodes; J W Fawcett
Journal:  J Anat       Date:  2004-01       Impact factor: 2.610

Review 2.  Sulfated glycosaminoglycans in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji; Kenji Uchimura
Journal:  Glycoconj J       Date:  2017-04-11       Impact factor: 2.916

3.  Heparan sulphate proteoglycan and the low-density lipoprotein receptor-related protein 1 constitute major pathways for neuronal amyloid-beta uptake.

Authors:  Takahisa Kanekiyo; Juan Zhang; Qiang Liu; Chia-Chen Liu; Lijuan Zhang; Guojun Bu
Journal:  J Neurosci       Date:  2011-02-02       Impact factor: 6.167

Review 4.  Protective Properties of Neural Extracellular Matrix.

Authors:  Anne Suttkus; Markus Morawski; Thomas Arendt
Journal:  Mol Neurobiol       Date:  2014-11-18       Impact factor: 5.590

5.  Glycosaminoglycans promote fibril formation by amyloidogenic immunoglobulin light chains through a transient interaction.

Authors:  Douglas J Martin; Marina Ramirez-Alvarado
Journal:  Biophys Chem       Date:  2011-05-18       Impact factor: 2.352

6.  Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species.

Authors:  T Toida; H Yoshida; H Toyoda; I Koshiishi; T Imanari; R E Hileman; J R Fromm; R J Linhardt
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

7.  Sulphated glycosaminoglycans prevent the neurotoxicity of a human prion protein fragment.

Authors:  M Pérez; F Wandosell; C Colaço; J Avila
Journal:  Biochem J       Date:  1998-10-15       Impact factor: 3.857

8.  Endoplasmic reticulum stress upregulates the chondroitin sulfate level which thus prevents neurite extension in C6 glioma cells and primary cultured astrocytes.

Authors:  Takamitsu Natori; Kaoru Nagai
Journal:  Cell Mol Neurobiol       Date:  2008-02-09       Impact factor: 5.046

9.  Tramiprosate, a drug of potential interest for the treatment of Alzheimer's disease, promotes an abnormal aggregation of tau.

Authors:  Ismael Santa-Maria; Félix Hernández; Joaquín Del Rio; Francisco J Moreno; Jesús Avila
Journal:  Mol Neurodegener       Date:  2007-09-06       Impact factor: 14.195

10.  Reduced molecular size and altered disaccharide composition of cerebral chondroitin sulfate upon Alzheimer's pathogenesis in mice.

Authors:  Zui Zhang; Shiori Ohtake-Niimi; Kenji Kadomatsu; Kenji Uchimura
Journal:  Nagoya J Med Sci       Date:  2016-08       Impact factor: 1.131

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.